Cencora (COR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $341.41, +1.56% vs the prior close of $336.17.
- Volume 1.59M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
COR rises 1.6% to $341.41, a 6-month high, 9 up days in a row. Closed at $341.41, +1.56% vs the prior close of $336.17. Day range $339.26–$345.46, opened at $342.70.
COR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — COR rises 1.6% to $341.41, a 6-month high, 9 up days in a row
- Closed at $341.41, +1.56% vs the prior close of $336.17. Day range $339.26–$345.46, opened at $342.70.
- Volume was 1.59M shares, 1.2x its 50-day average of 1.30M.
- Price is +6.7% vs its 50-day average ($319.93) and +7.5% vs its 200-day average ($317.48).
- 52-week range $244.82–$377.54; today's close sits at 73% of that range, 9.6% below the 52-week high.
- That makes 9 straight gains.
Oct 14, 2026 — COR rises 1.8% to $336.17, a 1-month high, 8 up days in a row
- Closed at $336.17, +1.84% vs the prior close of $330.11. Day range $330.82–$336.33, opened at $332.08.
- Volume was 1.19M shares, 0.9x its 50-day average of 1.33M.
- Price is +5.2% vs its 50-day average ($319.45) and +5.9% vs its 200-day average ($317.47).
- 52-week range $244.82–$377.54; today's close sits at 69% of that range, 11.0% below the 52-week high.
- That makes 8 straight gains.
Oct 13, 2026 — COR rises 1.6% to $330.11, a 1-month high, 7 up days in a row
- Closed at $330.11, +1.55% vs the prior close of $325.06. Day range $327.11–$331.60, opened at $328.07.
- Volume was 1.11M shares, 0.8x its 50-day average of 1.34M.
- Price is +3.5% vs its 50-day average ($318.85) and +4.0% vs its 200-day average ($317.50).
- 52-week range $244.82–$377.54; today's close sits at 64% of that range, 12.6% below the 52-week high.
- That makes 7 straight gains.
Oct 12, 2026 — COR rises 0.4% to $325.06, 6 up days in a row
- Closed at $325.06, +0.37% vs the prior close of $323.85. Day range $323.64–$327.96, opened at $325.37.
- Volume was 959.20K shares, 0.7x its 50-day average of 1.34M.
- Price is +2.1% vs its 50-day average ($318.41) and +2.4% vs its 200-day average ($317.55).
- 52-week range $244.82–$377.54; today's close sits at 60% of that range, 13.9% below the 52-week high.
- That makes 6 straight gains.
Oct 9, 2026 — COR rises 0.8% to $323.85, 5 up days in a row
- Closed at $323.85, +0.78% vs the prior close of $321.35. Day range $318.79–$325.82, opened at $319.50.
- Volume was 781.90K shares, 0.6x its 50-day average of 1.34M — lighter than usual.
- Price is +1.8% vs its 50-day average ($318.14) and +2.0% vs its 200-day average ($317.62).
- 52-week range $244.82–$377.54; today's close sits at 60% of that range, 14.2% below the 52-week high.
- That makes 5 straight gains.
Oct 8, 2026 — COR rises 1.3% to $321.35, 4 up days in a row
- Closed at $321.35, +1.29% vs the prior close of $317.25. Day range $314.90–$322.58, opened at $316.59.
- Volume was 897.60K shares, 0.7x its 50-day average of 1.35M.
- Price is +1.1% vs its 50-day average ($317.91) and +1.1% vs its 200-day average ($317.71).
- 52-week range $244.82–$377.54; today's close sits at 58% of that range, 14.9% below the 52-week high.
- That makes 4 straight gains.
Oct 7, 2026 — COR ends flat (+0.3%) to $317.25, 3 up days in a row
- Closed at $317.25, +0.28% vs the prior close of $316.37. Day range $315.15–$322.41, opened at $317.30.
- Volume was 1.06M shares, 0.8x its 50-day average of 1.35M.
- Price is -0.2% vs its 50-day average ($317.85) and -0.2% vs its 200-day average ($317.80).
- 52-week range $244.82–$377.54; today's close sits at 55% of that range, 16.0% below the 52-week high.
- That makes 3 straight gains.
Oct 6, 2026 — COR rises 0.5% to $316.37
- Closed at $316.37, +0.46% vs the prior close of $314.93. Day range $311.83–$316.44, opened at $314.63.
- Volume was 817.90K shares, 0.6x its 50-day average of 1.35M.
- Price is -0.5% vs its 50-day average ($317.90) and -0.5% vs its 200-day average ($317.92).
- 52-week range $244.82–$377.54; today's close sits at 54% of that range, 16.2% below the 52-week high.
Oct 5, 2026 — COR rises 1.9% to $314.93
- Closed at $314.93, +1.90% vs the prior close of $309.05. Day range $307.87–$316.06, opened at $309.43.
- Volume was 1.15M shares, 0.9x its 50-day average of 1.35M.
- Price is -0.9% vs its 50-day average ($317.79) and -1.0% vs its 200-day average ($318.05).
- 52-week range $244.82–$377.54; today's close sits at 53% of that range, 16.6% below the 52-week high.
Oct 2, 2026 — COR ends flat (-0.2%) to $309.05
- Closed at $309.05, -0.24% vs the prior close of $309.78. Day range $302.14–$310.43, opened at $308.29.
- Volume was 1.16M shares, 0.9x its 50-day average of 1.35M.
- Price is -2.7% vs its 50-day average ($317.69) and -2.9% vs its 200-day average ($318.19).
- 52-week range $244.82–$377.54; today's close sits at 48% of that range, 18.1% below the 52-week high.
COR latest news & SEC filings
Every SEC filing by or about COR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sanchez Robert E received an award of 275 shares on Oct 1, 2026; now holds 275
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Krikorian Lazarus sold 986 shares at $303.18 (≈$298.94K) on Oct 1, 2026; now holds 15,183
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 25, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 17, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Greenberg Lon R sold 1,280 shares at $321.30 (≈$411.26K) on Sep 16, 2026; now holds 17,128
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 12, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $84.75B (prior year $80.66B) (+5.1% vs Jun 30, 2025)
- Net income: $763.52M (prior year $687.40M) (+11.1% vs Jun 30, 2025)
- Diluted EPS: $3.94 (prior year $3.52) (+11.9% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 18, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade COR
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.19% (largest 3.2%).
- Liquidity: about 1.28M shares (≈$437.82M) trade per day on average.
- 52-week position: $341.41 vs a range of $244.82–$377.54 (73% of the range).
- Dividends: last ex-dividend date Aug 14, 2026 ($0.6/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 3 open-market buys, 13 sales; latest: Lon R Greenberg sold 1,280 shares on Sep 16, 2026.
- Latest filings: 8-K Sep 25, 2026; 8-K Aug 14, 2026; 8-K Aug 12, 2026.
- Share count: 190.83M shares outstanding (Jul 31, 2026), -1.6% vs a year earlier.
- Listing: NYSE · industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries.
COR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 342.70 | 345.46 | 339.26 | 341.41 | 1.59M |
| Oct 14, 2026 | 332.08 | 336.33 | 330.82 | 336.17 | 1.19M |
| Oct 13, 2026 | 328.07 | 331.60 | 327.11 | 330.11 | 1.11M |
| Oct 12, 2026 | 325.37 | 327.96 | 323.64 | 325.06 | 959.20K |
| Oct 9, 2026 | 319.50 | 325.82 | 318.79 | 323.85 | 781.90K |
| Oct 8, 2026 | 316.59 | 322.58 | 314.90 | 321.35 | 897.60K |
| Oct 7, 2026 | 317.30 | 322.41 | 315.15 | 317.25 | 1.06M |
| Oct 6, 2026 | 314.63 | 316.44 | 311.83 | 316.37 | 817.90K |
| Oct 5, 2026 | 309.43 | 316.06 | 307.87 | 314.93 | 1.15M |
| Oct 2, 2026 | 308.29 | 310.43 | 302.14 | 309.05 | 1.16M |
| Oct 1, 2026 | 303.18 | 313.02 | 300.77 | 309.78 | 1.89M |
| Sep 30, 2026 | 306.40 | 306.40 | 295.01 | 300.25 | 1.81M |
| Sep 29, 2026 | 300.00 | 307.62 | 298.21 | 307.60 | 1.27M |
| Sep 28, 2026 | 306.20 | 307.94 | 302.84 | 303.81 | 1.52M |
| Sep 25, 2026 | 308.95 | 310.89 | 304.31 | 306.92 | 1.08M |
| Sep 24, 2026 | 313.32 | 316.61 | 309.18 | 309.87 | 1.08M |
| Sep 23, 2026 | 315.51 | 320.24 | 310.71 | 312.28 | 1.10M |
| Sep 22, 2026 | 317.62 | 320.00 | 313.89 | 314.43 | 775.70K |
| Sep 21, 2026 | 309.74 | 316.98 | 308.51 | 316.49 | 1.05M |
| Sep 18, 2026 | 307.42 | 311.81 | 304.45 | 308.78 | 3.34M |
About Cencora
Cencora (COR) is listed on the NYSE and classified by the SEC under “Wholesale-Drugs, Proprietaries & Druggists' Sundries”. Its business address is in CONSHOHOCKEN, PA. State of incorporation: DE. Fiscal year ends September 30. SEC CIK 1140859.
COR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Werner Baumann | Director | Mar 9, 2026 |
| Frank Clyburn | Director | Mar 9, 2026 |
| Ellen Cooper | Director | Aug 4, 2026 |
| Dermot Mark Durcan | Director | Jun 22, 2026 |
| Lon R Greenberg | Director | Sep 17, 2026 |
| Lorence H. Kim | Director | Mar 9, 2026 |
| Robert P. Mauch | President & CEO | Feb 24, 2026 |
| Redonda Miller | Director | Mar 9, 2026 |
| Dennis M Nally | Director | Aug 4, 2026 |
| Lori Ryerkerk | Director | Mar 9, 2026 |
| Lauren M Tyler | Director | Aug 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Silvana Battaglia | Executive Vice President | Jul 7, 2026 |
| Eva C Boratto | Chief Financial Officer | Jun 30, 2026 |
| Elizabeth S Campbell | Executive Vice President | Aug 25, 2026 |
| James F Cleary | Chief Financial Officer | Mar 13, 2026 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | Sep 2, 2026 |
| Robert P. Mauch | President & CEO | Feb 24, 2026 |
| Pawan Verma | EVP, Chief Data & Info Officer | Nov 24, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Lon R Greenberg | Sale | 1,280 | $321.30 |
| Sep 1, 2026 | Lazarus Krikorian | Sale | 985 | $325.97 |
| Aug 24, 2026 | Elizabeth S Campbell | Sale | 11,300 | $324.12 |
| Jun 22, 2026 | Lauren M Tyler | Buy | 550 | $270.23 |
| Jun 18, 2026 | Dermot Mark Durcan | Buy | 4,000 | $274.19 |
| May 28, 2026 | Dermot Mark Durcan | Buy | 4,000 | $266.26 |
| Feb 20, 2026 | Robert P. Mauch | Sale | 3,762 | $358.94 |
| Feb 18, 2026 | Robert P. Mauch | Sale | 1,333 | $359.46 |
| Jan 20, 2026 | Robert P. Mauch | Sale | 5,096 | $354.73 |
| Dec 19, 2025 | Elizabeth S Campbell | Sale | 3,351 | $342.10 |
| Dec 19, 2025 | Silvana Battaglia | Sale | 1,677 | $345.00 |
| Dec 18, 2025 | Robert P. Mauch | Sale | 5,096 | $343.45 |
| Dec 17, 2025 | Lazarus Krikorian | Sale | 4,031 | $343.24 |
| Nov 18, 2025 | Robert P. Mauch | Sale | 5,096 | $366.64 |
| Oct 20, 2025 | Robert P. Mauch | Sale | 5,097 | $326.80 |
COR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | $321.33B | $1.55B | 7.96 | $3.88B |
| Sep 30, 2024 | $293.96B | $1.51B | 7.53 | $3.48B |
| Sep 30, 2023 | $262.17B | $1.75B | 8.53 | $3.91B |
| Sep 30, 2022 | $238.59B | $1.70B | 8.04 | $2.70B |
| Sep 30, 2021 | $213.99B | $1.54B | 7.39 | $2.67B |
Latest balance sheet: total assets $83.81B, total liabilities $—, cash $2.82B (as of Jun 30, 2026).
COR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $317.22 |
| May 6, 2026 | 8-K Item 2.02 (results) | $252.74 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $329.97 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $354.00 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $283.78 |
| May 7, 2025 | 8-K Item 2.02 (results) | $304.58 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $253.28 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $245.38 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Mckesson (MCK)Cardinal Health (CAH)Herbalife (HLF)Nu Skin Enterprises (NUS)Cosmos Health (COSM)DataMeds AI (MEDS)Cellyan Biotechnology (HKPD)HWH International (ESYN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on COR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.